Routine TP53 testing for breast cancer under age 30: ready for prime time? - Test2 - elhamkhani - TriplyDB

Routine TP53 testing for breast cancer under age 30: ready for prime time?

Routine TP53 testing for breast cancer under age 30: ready for prime time?

http://www.wikidata.org/entity/Q47317433

about

Connecting molecular pathways to hereditary cancer risk syndromes Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.Identification of a comprehensive spectrum of genetic factors for hereditary breast cancer in a Chinese population by next-generation sequencing.Germline TP53 mutational spectrum in French Canadians with breast cancer.Ovarian cancer: in search of better marker systems based on DNA repair defects Early-onset breast cancer patients in the South and Southeast of Brazil should be tested for the TP53 p.R337H mutation Germline TP53 Mutation and Clinical Characteristics of Korean Patients With Li-Fraumeni Syndrome Genomic Disparities in Breast Cancer Among Latinas.Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation status.TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families.Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.Hereditary breast cancer syndromes and genetic testing.Next generation sequencing is informing phenotype: a TP53 example.Clinical Outcomes of TP53 Mutations in Cancers.Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition.Inherited TP53 Mutations and the Li-Fraumeni Syndrome.Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.Assessment of TP53 Polymorphisms and MDM2 SNP309 in Premenopausal Breast Cancer Risk.Clinical implications of germline mutations in breast cancer: TP53.Increased access to TP53 analysis through breast cancer multi-gene panels: clinical considerations.An investigation of genetic counselors' testing recommendations: pedigree analysis and the use of multiplex breast cancer panel testing.Prevalence of deleterious mutations among patients with breast cancer referred for multigene panel testing in a Romanian population.Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity

P2860

Q28291516-8A2F4AAC-6791-49E0-9AD8-2F57754953BD Q28389268-669FB26D-C55E-4C7A-8AF3-CC0A8CFA56D6 Q33768942-924858D9-9107-495E-AC47-BF5237E2D86D Q34324683-4F709AB6-9493-4988-AE4D-296C942843F2 Q35558112-83F967D4-520D-47CA-A815-576D3A24BDD1 Q35618321-55DE997D-7D14-41E4-8C74-36964C434E81 Q36589947-77D01619-5E36-486D-82D3-AF9B111FA9F8 Q37011925-96112A62-6EA5-4EF2-8613-72FFF0D29D8D Q37084148-FAEF70B4-7D19-4C9C-98D5-C8E362BC51D0 Q37509093-DFE302A3-ADDB-4B31-9D93-D4019FC7E66B Q37583113-AD9401A4-7796-4670-BD27-F6B6E0D65483 Q37716648-80BA3FF7-DC78-46FD-80E2-7E5731307396 Q38202612-3C1C8FA6-B82E-4544-A1BD-D6ACF7852679 Q38266306-3660E6B3-808E-45D1-AD50-9F8A17DC4C14 Q38783154-34F54576-4B8E-4F4A-8402-92FB4EFA7BD1 Q38906201-C3C01F9F-8ACE-464B-B4D3-4FB75822EF80 Q38979257-3312FB79-C928-43EA-BF80-CBFB5E98A008 Q39041480-160DD1FC-5E09-49F2-8E5B-BFE6DA22AB5F Q39167055-70084FD1-F8E9-47FF-BD2E-9875E940C5FE Q40633720-6D7BA594-7BB5-4D29-9F51-702A17B60CD4 Q46031098-8B2F1A23-8F8E-4016-8364-F636FFEA38EF Q47607437-4BD50FF4-25CB-4FDA-BDFC-720FB323B870 Q48170008-9C0FEAC9-653D-40A2-9BD7-8FF673654F42 Q54453284-6383227F-8060-4826-BC6B-3EFB360352D2 Q55280273-80EFE071-F5CC-454D-A10E-4F766043EF2D Q58797665-D6CE45BC-5D8C-4ACC-9E0C-99A1B41D3513

P2860

Routine TP53 testing for breast cancer under age 30: ready for prime time?

http://www.wikidata.org/entity/Q47317433

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Routine TP53 testing for breast cancer under age 30: ready for prime time?

@en

Routine TP53 testing for breast cancer under age 30: ready for prime time?

@nl

type

label

Routine TP53 testing for breast cancer under age 30: ready for prime time?

@en

Routine TP53 testing for breast cancer under age 30: ready for prime time?

@nl

prefLabel

Routine TP53 testing for breast cancer under age 30: ready for prime time?

@en

Routine TP53 testing for breast cancer under age 30: ready for prime time?

@nl

P1433

Q47317433-0224FAB9-9337-414F-8D20-F86E261A1457

P1476

Q47317433-4E8F258D-446E-4115-9043-18312DCC4882

P2093

Q47317433-84FF4990-20DC-491C-A82A-4ED8D4FD40E8

Q47317433-88C8937E-E725-4B97-92E9-5CF56F75DE8E

Q47317433-9ACFFF64-B209-4E4C-B744-D60AD7C8FE43

Q47317433-D983E783-8A64-4ADF-BA3A-A94625210BA7

Q47317433-F903AEC1-422C-448A-886B-C978B30F35AE

Q47317433-FB70A7D4-344D-4F9A-BB5D-B561EBE26A5B

P2860

Q47317433-12D2902C-B12B-44AF-ACB8-4B76B0900760

Q47317433-1400267B-0540-4597-B8CB-697671812C80

Q47317433-1CEDC366-531B-453B-B9AF-C68CFE0C1ACE

Q47317433-20B8E1B3-6D6A-4C91-8FF2-287E56B2A768

Q47317433-3CFB2D5E-BE93-459C-9C7F-3C13F4FE1614

Q47317433-5A292434-7638-4E68-9AC1-B2AD641B7570

Q47317433-609D7C00-F5AC-41D6-BFB2-D310A31BDB27

Q47317433-7907BDD9-169C-40F8-8C2E-8CDF2CE51BA8

Q47317433-79FCB77F-CD0C-4CC3-9771-AD1226DDC132

Q47317433-7F94083D-EEAE-4D43-B28F-3A55B9313CC0

P2888

Q47317433-253472F8-7BC9-41BC-AE58-381F6FC95EF3

P304

Q47317433-D3986974-7229-4AD7-920B-0CB804FD0A68

P31

Q47317433-322BD72A-8C1E-4482-970D-3CCE56A15737

P356

Q47317433-BB1B26C0-D26F-4F69-9F61-88800F615FF1

P433

Q47317433-6DB6F297-588E-467A-BB72-6458B82B0C28

P478

Q47317433-32D884CC-8AFE-4739-BE4F-977E67108E5C

P50

Q47317433-9FCE580D-449A-43D1-A68D-92F62162DB23

P577

Q47317433-957E8EEA-9364-4CD7-8B16-B978C0174EA1

P5875

Q47317433-0FF184CC-79B4-4635-BEF4-E9D01E3E21A2

P698

Q47317433-8D0F5022-D87C-4FEB-8A84-95327364AED3

P356

S10689-012-9557-Z

P1433

Familial Cancer

P1476

Routine TP53 testing for breast cancer under age 30: ready for prime time?

@en

P2093

Ana Novokmet

http://www.w3.org/2001/XMLSchema#string

David Malkin

http://www.w3.org/2001/XMLSchema#string

Jeanna M McCuaig

http://www.w3.org/2001/XMLSchema#string

Ophira M Ginsburg

http://www.w3.org/2001/XMLSchema#string

Rochelle Demsky

http://www.w3.org/2001/XMLSchema#string

Susan R Armel

http://www.w3.org/2001/XMLSchema#string

P2860

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

Unique de novo mutation of BRCA2 in a woman with early onset breast cancer

Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease.

Novel de novo BRCA2 mutation in a patient with a family history of breast cancer

Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer

De novo recurrent germline mutation of the BRCA2 gene in a patient with early onset breast cancer.

Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study.

Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.

P2888

s10689-012-9557-z

P304

607-613

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10689-012-9557-Z

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Steven A. Narod

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230592565

http://www.w3.org/2001/XMLSchema#string

P698

22851211

http://www.w3.org/2001/XMLSchema#string